As of 2025-03-23, the Relative Valuation of Reneo Pharmaceuticals Inc (RPHM) is (14.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Reneo Pharmaceuticals Inc based on Relative Valuation is -918.1%.
The range of the Relative Valuation is (14.01) - (21.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 26.4x | 16.3x |
| Forward P/E multiples | 13.9x - 23.0x | 15.2x |
| Fair Price | (14.01) - (21.74) | (14.89) |
| Upside | -869.8% - -1294.7% | -918.1% |
| Date | P/E |